Skip to main content
SpringerLink
Log in

Radiation Therapy in the Treatment of Primary Liver Cancers

  • Reference work entry
  • First Online:
Image-Guided Cancer Therapy

  • 1441 Accesses

Abstract

Radiation therapy (RT), either in the form of external beam treatment or brachytherapy, is an effective modality for the treatment of primary hepatocellular cancer, and a meta-analysis has shown that the addition of RT in combination with other therapy enhances survival for HCC patients. The application of modern treatment delivery techniques has enabled the safe administration of faster, more potent hypofractionated RT regimens. Newer techniques such as selective internal radiation therapy (SIRT) and stereotactic body radiation therapy (SBRT) are especially promising, and the combination of RT and molecular-targeted therapies is currently under investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 269.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. International Agency for Cancer Research. GLOBOCAN 2008: cancer incidence and mortality worldwide in 2008. http://globocan.iarc.fr. Accessed 31 July 2010.

  2. Sanyal A, Poklepovic A, Moyneur E, Barghout V. Population-based risk factors and resource utilization for HCC: US perspective. Curr Med Res Opin. 2010;26(9):2183–91. Epub ahead of print.

    Article  CAS  PubMed  Google Scholar 

  3. Hasegawa K, Kokudo N. Surgical treatment of hepatocellular carcinoma. Surg Today. 2009;39(10):833–43. Epub 2009 Sep 27.

    Article  PubMed  Google Scholar 

  4. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56(4):918–28.

    Article  CAS  PubMed  Google Scholar 

  5. Yeung YP, Lo CM, Liu CL, et al. Natural history of untreated nonsurgical hepatocellular carcinoma. J Gastroenterol. 2005;100(9):1995–2004.

    Google Scholar 

  6. Ruzzenente A, Capra F, Pachera S, et al. Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients. J Gastrointest Surg. 2009;13(7):1313–20.

    Article  PubMed  Google Scholar 

  7. Stillwagon GB, Order SE, Guse C, et al. 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response: A Radiation Therapy Oncology Group study. Int J Radiat Oncol Biol Phys. 1989;17(6):1223–9.

    Article  CAS  PubMed  Google Scholar 

  8. Abrams RA, Cardinale RM, Enger C, et al. Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. Int J Radiat Oncol Biol Phys. 1997;39(5):1077–85.

    Article  CAS  PubMed  Google Scholar 

  9. Liu MT, Li SH, Chu TC, et al. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization. Jpn J Clin Oncol. 2004;34(9):532–9.

    Article  PubMed  Google Scholar 

  10. Ben-Josef E, Normolle D, Ensminger WD, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol. 2005;23:8739–47.

    Article  PubMed  Google Scholar 

  11. Hsu W, Chan S, Ting L, et al. Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma. Jpn J Clin Oncol. 2006;36(2):93–9.

    Article  PubMed  Google Scholar 

  12. Seo YS, Kim JN, Keum B, et al. Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma. World J Gastroenterol. 2008;14(15):2394–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Zeng Z, Fan J, Tang Z, et al. Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy. Cancer Sci. 2008;99(12):2510–7.

    Article  CAS  PubMed  Google Scholar 

  14. Han K, Seong J, Kim JK, et al. Chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis. Cancer. 2008;113:995–1003.

    Article  CAS  PubMed  Google Scholar 

  15. Zeng ZC, Tang ZY, Fan J, Qin LX, Ye SL, Zhou J, Sun HC, Wang BL, Wang JH. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys. 2005;63(4):1067–76.

    Article  PubMed  Google Scholar 

  16. McIntosh A, Hagspiel KD, Al-Osaimi AM, et al. Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. Cancer. 2009;115:5117–25.

    Article  CAS  PubMed  Google Scholar 

  17. Rich TA, Shepard RC, Mosley ST. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. J Clin Oncol. 2004;22:2214–32.

    Article  CAS  PubMed  Google Scholar 

  18. Kavanagh BD, Timmerman RD. Stereotactic body radiation therapy. Philadelphia: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  19. Liang S-X, Jiang GL, Zhu X-D, et al. Hypofractionated 3-dimensional conformal radiation therapy for primary liver carcinoma. Cancer. 2005;103:2181–8.

    Article  PubMed  Google Scholar 

  20. Choi BO, Jang HS, Kang KM, et al. Fractionated stereotactic radiotherapy in patients with primary hepatocellular carcinoma. Jpn J Clin Oncol. 2006;36(3):154–8.

    Article  PubMed  Google Scholar 

  21. Bush DA, Hillebrand DJ, Slater JM, et al. High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial. Gastroenterology. 2004;127:S189–93.

    Article  PubMed  Google Scholar 

  22. Fukumitsu N, Sugahara S, Nakayama H, et al. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2009;74(3):831–6.

    Article  PubMed  Google Scholar 

  23. Tse RV, Hawkins M, Lockwood G, et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2008;26:657–64.

    Article  PubMed  Google Scholar 

  24. Méndez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i-ii study. Acta Oncol. 2006;45(7):831–7.

    Article  PubMed  Google Scholar 

  25. Choi BO, Choi BI, Jang HS, et al. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. BMC Cancer. 2008;8:351.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Son SH, Choi BO, Ryu MR, et al. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication. Int J Radiat Oncol Biol Phys. 2010;78(4):1073–80. Epub ahead of print.

    Article  PubMed  Google Scholar 

  27. Cardenes HR, Price TR, Perkins SM, et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol. 2010;12(3):218–25.

    Article  CAS  PubMed  Google Scholar 

  28. Meng M, Cui Y, She B, et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol. 2009;92(2):184–94.

    Article  PubMed  Google Scholar 

  29. Oh D, Lim d H, Park HC. Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: a prospective evaluation of efficacy and toxicity. Am J Clin Oncol. 2010;33(4):370–5.

    Article  CAS  PubMed  Google Scholar 

  30. Ren Z, Zhao H, Chen Z, et al. Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study. Int J Radiat Oncol Biol Phys. 2010. [Epub ahead of print].

    Google Scholar 

  31. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–90.

    Article  CAS  PubMed  Google Scholar 

  32. Chi K, Liao C, Chand C, et al. Angiogenic blockade and radiotherapy in hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2010;78(1):188–93. Epub ahead of print.

    Article  PubMed  Google Scholar 

  33. Zhao J, Liu J, Ren Z, et al. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study. Radiat Oncol. 2010;5:12. doi:10.1186/1748-717X-5-12.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Mohnike K, Wieners G, Schwartz F, et al. Computed tomography–guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys. 2010;78(1):172. Epub ahead of print.

    Article  PubMed  Google Scholar 

  35. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies part 1: technical and methodologic considerations treatment is administered via the hepatic artery. J Vasc Interv Radiol. 2006;17:1251–78.

    Article  PubMed  Google Scholar 

  36. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies part 2: special topics. J Vasc Interv Radiol. 2006;17:1425–39.

    Article  PubMed  Google Scholar 

  37. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies part 3: comprehensive literature review and future direction. J Vasc Interv Radiol. 2006;17:1571–94.

    Article  PubMed  Google Scholar 

  38. Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol. 2005;16:195–203.

    Article  PubMed  Google Scholar 

  39. Keppke AL, Salem R, Reddy D, et al. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. Am J Roentgenol (AJR). 2007;188:768–75.

    Article  Google Scholar 

  40. Welsh JS. Radiographically identified necrosis after 90Y microsphere brachytherapy: a new standard for oncologic response assessment? Am J Roentgenol (AJR). 2007;188:765–7.

    Article  Google Scholar 

  41. Riaz A, Kulick L, Lewandowski RJ, et al. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using Yttrium-90 microspheres. Hepatology. 2009;49:1–9.

    Article  Google Scholar 

  42. Detry O, De Roover A, Delwaide J, et al. Absolute and relative contraindications to liver transplantation. A perpetually moving frontier. Acta Gastroenterol Belg. 2002;65:133–4.

    PubMed  Google Scholar 

  43. Lewandowski RJ, Kulik LM, Riaz SS, et al. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant. 2009;9:1–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of Colorado School of Medicine, 1665 Aurora Court, Suite 1032, Aurora, CO, 80045, USA

    Brian D. Kavanagh & Tracey E. Schefter

Authors
  1. Brian D. Kavanagh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tracey E. Schefter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian D. Kavanagh .

Editor information

Editors and Affiliations

  1. The Warren Alpert Medical School of Brown University, Department of Diagnostic Imaging Rhode Island Hospital, Providence, Rhode Island, USA

    Damian E. Dupuy

  2. Department of Surgery and Radiology Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Yuman Fong

  3. McMullen Consulting, LLC, Surprise, Arizona, USA

    William N. McMullen

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this entry

Cite this entry

Kavanagh, B.D., Schefter, T.E. (2013). Radiation Therapy in the Treatment of Primary Liver Cancers. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0751-6_27

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0750-9

  • Online ISBN: 978-1-4419-0751-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation